Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × eribulin × Clear all

NCT00278993 2014-07-14

Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy

Phase 2 Completed

108 enrolled 11 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00337077 2014-06-23

Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

121 enrolled 8 charts

Prostatic Neoplasms